Projects per year
- 450 - 500 out of 502 results
Search results
-
Non Profit
HEALEY ALS Platform Trial - Regimen-Specific Appendix C - For CNM-Au8
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
Novel platform technologies for RNA vaccines WP1: Design of vaccine candidates
2/1/24 → 7/31/25
Project: Non Profit
-
-
-
-
-
Quantification and Distribution of a Novel Nanoparticle Designed to Target the Cardiac Conduction System
9/1/23 → 8/31/25
Project: Non Profit
-
Alternative polyadenylation in heart failure
Amirthalingam Thandavarayan, R.
4/1/23 → 3/31/26
Project: Non Profit
-
-
Prevention of De Novo HCV with Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
9/18/18 → 9/17/43
Project: Non Profit
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H., Darcourt, J. & Singh, M.
6/11/13 → 6/10/38
Project: Non Profit
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
Bernicker, E. H. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
-
Liver Transplant Oncology Program: a strategy for improving post-transplant outcomes
7/1/23 → 6/30/25
Project: Non Profit
-
Novel platform technologies for RNA vaccines WP3: Preclinical small animal
2/1/24 → 7/31/25
Project: Non Profit
-
MGH Healey Platform Trial Regimen-Specific Appendix F - ABBV-CLS-7262
5/31/23 → 7/23/25
Project: Non Profit
-
Eradication of Advanced Prostate Cancer by Chimeric Antigen Receptor-T Cell Therapy with A Safety Switch
1/1/24 → 12/31/25
Project: Non Profit
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
Novel potential drug targets for treatment of triple-negative breast cancer
10/1/23 → 9/30/24
Project: Non Profit
-
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Novel platform technologies for RNA vaccines WP5: Large animal efficacy studies
2/1/24 → 7/31/25
Project: Non Profit
-
NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.
3/12/19 → 2/28/25
Project: Non Profit
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
-
Massachusetts General Hospital Healey Center for ALS - Healey ALS Platform Trial
Appel, S. H., Shroff, S., Greene, E. P. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
State
Sexual Assault Nurse Examiner (SANE) expansion, Houston Methodist West
9/1/23 → 8/31/24
Project: State
-
Development of stable mRNA cancer vaccines using RNA-plex biotechnology
9/1/23 → 8/31/24
Project: State
-
-
Development of a computational platform to streamline neoantigen selection
9/1/23 → 8/31/24
Project: State
-
-
-
Texas Southern University Breast Cancer Prevention and Screening Center (TSU BCSPC)
10/1/21 → 8/30/24
Project: State
-
-
-
Sexual Assault Nurse Examiner (SANE) expansion, Houston Methodist Willowbrook
9/1/23 → 8/31/24
Project: State
-
-
Targeting Sodium Hydrogen Exchanger 6 to Improve the Efficacy of Chemotherapy and Immunotherapy for Multiple Myeloma
12/1/22 → 11/30/24
Project: State